copper gluconate has been researched along with Dyslipidemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asbaghi, O; Fouladvand, F; Khodadost, M; Nasiri, M; Panahande, B; Pirouzi, A; Sadeghi, O; Sadeghian, M; Shokri, A | 1 |
| Artigas, CF; Espino Ibáñez, A; Masmiquel Comas, L; Nicolau Ramis, J; Rivera Irigoín, R | 1 |
1 review(s) available for copper gluconate and Dyslipidemias
| Article | Year |
|---|---|
Effects of zinc supplementation on lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Aged; Biomarkers; Diabetes Mellitus, Type 2; Dietary Supplements; Dyslipidemias; Female; Gluconates; Humans; Lipids; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Zinc Sulfate | 2020 |
1 other study(ies) available for copper gluconate and Dyslipidemias
| Article | Year |
|---|---|
[Extrapyramidal symptoms due to calcinosis cerebri in a patient with unknown primary hypoparathyroidism].
Topics: Basal Ganglia Diseases; Brain Diseases, Metabolic; Calcinosis; Calcitriol; Calcium; Cognition Disorders; Depressive Disorder; Diagnosis, Differential; Dyslipidemias; Female; Gait Disorders, Neurologic; Gluconates; Humans; Hypoparathyroidism; Levodopa; Magnesium; Middle Aged; Syndrome | 2012 |